These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11469724)

  • 1. Hepatic cytochrome P450 regulation in disease states.
    Cheng PY; Morgan ET
    Curr Drug Metab; 2001 Jun; 2(2):165-83. PubMed ID: 11469724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytochrome P450 activity and its alteration in different diseases].
    Orellana M; Guajardo V
    Rev Med Chil; 2004 Jan; 132(1):85-94. PubMed ID: 15379059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cytochromes P450 during inflammation and infection.
    Morgan ET
    Drug Metab Rev; 1997 Nov; 29(4):1129-88. PubMed ID: 9421688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 regulation and drug biotransformation during inflammation and infection.
    Renton KW
    Curr Drug Metab; 2004 Jun; 5(3):235-43. PubMed ID: 15180493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic drug metabolism and immunostimulation.
    Renton KW
    Toxicology; 2000 Jan; 142(3):173-8. PubMed ID: 10667888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.
    Morgan ET; Skubic C; Lee CM; Cokan KB; Rozman D
    Drug Metab Rev; 2020 Nov; 52(4):455-471. PubMed ID: 32898444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet.
    Yoshinari K; Takagi S; Yoshimasa T; Sugatani J; Miwa M
    Pharm Res; 2006 Jun; 23(6):1188-200. PubMed ID: 16715367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice.
    Roe AL; Howard G; Blouin R; Snawder JE
    Int J Obes Relat Metab Disord; 1999 Jan; 23(1):48-53. PubMed ID: 10094576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation.
    Iber H; Li-Masters T; Chen Q; Yu S; Morgan ET
    J Pharmacol Exp Ther; 2001 Apr; 297(1):174-80. PubMed ID: 11259542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of hepatic cytochrome P450 enzymes in rats with trinitrobenzene sulfonic acid-induced colitis.
    Masubuchi Y; Enoki K; Horie T
    Drug Metab Dispos; 2008 Mar; 36(3):597-603. PubMed ID: 18079364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The signal transduction pathways involved in hepatic cytochrome P450 regulation in the rat during a lipopolysaccharide-induced model of central nervous system inflammation.
    Abdulla D; Goralski KB; Del Busto Cano EG; Renton KW
    Drug Metab Dispos; 2005 Oct; 33(10):1521-31. PubMed ID: 16006567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.
    Renton KW; Nicholson TE
    J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
    Ling S; Jamali F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes.
    Barnett CR; Abbott RA; Bailey CJ; Flatt PR; Ioannides C
    Biochem Pharmacol; 1992 Apr; 43(8):1868-71. PubMed ID: 1575780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 21-aminosteroids prevent the down-regulation of hepatic cytochrome P450 induced by hypoxia and inflammation in conscious rabbits.
    Galal A; Souich P
    Br J Pharmacol; 1999 Sep; 128(2):374-9. PubMed ID: 10510447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes.
    Shimojo N; Ishizaki T; Imaoka S; Funae Y; Fujii S; Okuda K
    Biochem Pharmacol; 1993 Aug; 46(4):621-7. PubMed ID: 8363636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats.
    Masubuchi Y; Kawasaki M; Horie T
    Arch Toxicol; 2006 Jun; 80(6):347-53. PubMed ID: 16485119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the CYP3A and CYP2C11 enzymes in a nutritionally obese rodent model: response to phenobarbital treatment.
    Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
    Int J Obes Relat Metab Disord; 1994 Jun; 18(6):369-74. PubMed ID: 8081427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes.
    Yoda N; Emoto C; Date S; Kondo S; Miyake M; Nakazato S; Umehara K; Kashiyama E
    Xenobiotica; 2012 Aug; 42(8):719-30. PubMed ID: 22324396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.